Status | Study |
Completed |
Study Name: Do Your Genes Put You at a Higher Risk of Developing Mesothelioma Condition: Mesothelioma Date: 2012-04-23 |
Completed |
Study Name: SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma Condition: Mesothelioma Date: 2011-09-30 Interventions: Biological: Multicycle SS1P As |
Withdrawn |
Study Name: A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma Condition: Malignant Pleural Mesothelioma Date: 2011-05-11 Interventions: Drug: Cisplatin Cisplatin (75m |
Completed |
Study Name: Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) Condition: Mesothelioma Date: 2010-09-15 Interventions: Drug: Zometa Zoledronic acid will be administered IV on the first day of a 21 day cycle at a concentrati |
Active, not recruiting |
Study Name: Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy Condition: Pleural Mesothelioma Peritoneal Mesotheli Date: 2010-07-09 Interventions: Drug: IMC-A12 20 mg/kg intravenous over 60 minutes or not to exceed 25 mg/minute once every 3 weeks (+ o |
Recruiting |
Study Name: Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma Condition: Mesothelioma Date: 2009-10-14 Interventions: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin) One cycle is defined as an interval of 28 days. A |
Completed |
Study Name: Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma Condition: Mesothelioma Date: 2009-03-09 Interventions: Drug: Oxaliplatin/Gemcitabine Gemcitabine 1000mg/m2 IV infusion for 90 minutes followed by oxaliplatin 1 |
Terminated |
Study Name: An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma Condition: Mesothelioma Date: 2008-01-09 Interventions: Drug: Vinorelbine Other Name: |
Completed |
Study Name: Tomotherapy Treatment for Mesothelioma Condition: Mesothelioma Date: 2007-05-02 Interventions: Procedure: Tomotherapy 40 Gy in 15 fractions, at one fraction per day. Dose will be prescribed to the 95 |
Completed |
Study Name: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma Condition: Mesothelioma Date: 2006-11-20 Interventions: Drug: Cisplatin Starting Dose: |